Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Pakistan-China pharma conference ends with $850m agreements
• Health minister says 16 contracts, 80 MoUs finalised • Agreements include 18 deals related to herbal medicines ISLAMABAD: Pakistan's agreements with Chinese companies reached $850 million on the concluding day of the two-day…
Chemists demand fair competition in pharma market amid online sales concerns
The All India Organisation of Chemists and Druggists (AIOCD) on Sunday (July 19, 2026) demanded that the government ensure an equitable ecosystem for all the players to sustain in the market by ensuring a level playing field. At its sixth…
Alembic Pharma partner NATCO gets USFDA tentative nod for generic Olaparib tablets; US market size at $1.4 bn
Alembic Pharmaceuticals said its partner NATCO Pharma has received tentative approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Olaparib Tablets in 100 mg and 150 mg strengths, a…
The market for psychedelic drugs to treat mental health conditions gets a big buy signal
Thursday's announcement that Eli Lilly will acquire AtaiBeckley, a clinical-stage maker of psychedelic drugs, for up to $3.8 billion indicates Big Pharma's increasing embrace of a long-stigmatized class of medications as alternatives for treating…
Fake medicine manufacturing unit busted in Uttarakhand, 1 held
The Uttarakhand police's Special Task Force (STF) busted a gang involved in the manufacturing spurious allopathic medicines without a valid license, police said on Sunday. In a joint operation with the Drug Administration Department, the STF raided…
Teva stock's downward trend continues
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA ; TASE: TEVA) ended the trading week on Wall Street down 2.8% with falls on four of the five sessions last week. In fact, except for two trading days in early July and one trading day last week, the…
Is It Too Late to Buy Johnson & Johnson After Its Blowout Earnings Report?
Johnson & Johnson (JNJ +1.22%) has been a top-performing stock this year. Investors, in many cases rotating out of riskier assets, have looked for companies with a strong track record of earnings growth, solid competitive positions, and a revenue…
How drug companies are playing hardball with Australia's PBS
Australia is coming under increasing pressure from international drug companies demanding higher prices for their drugs. In some cases, negotiations have broken down and companies have said they'll withdraw their drugs from the market. In other…
Promising Growth Stocks Worth Watching - July 19th
Prologis Q1 2026: Data Centers Steal the Show Prologis, Teledyne Technologies, Ascendis Pharma A/S, Pattern Group, Hamilton Lane, Acadia Realty Trust, and Andersen Group are the seven Growth stocks to watch today, according to MarketBeat's stock…
SEB Asset Management AB Invests $59.55 Million in Teva Pharmaceutical Industries Ltd. $TEVA
SEB Asset Management AB bought a new stake in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 1,977,137…
Nightmare on Downing St - UK business issues vote of no confidence in new PM
“And things are likely to get worse, whoever Burnham appoints as his Chancellor.” UK firms issued an unequivocal assessment in DJH's Future of Business state-of-the-nation poll The pulse check poll exposes how more than two-thirds of…
S&CO Inc. Buys 1,310 Shares of Eli Lilly and Company $LLY
S&CO Inc. increased its stake in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 6.5% in the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 21,519 shares of the company's stock after buying an…
Allspring Global Investments Holdings LLC Sells 159,581 Shares of Teva Pharmaceutical Industries Ltd. $TEVA
Allspring Global Investments Holdings LLC lessened its holdings in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) by 8.7% during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission.
Eli Lilly and Company $LLY Shares Sold by Jennison Associates LLC
Jennison Associates LLC lowered its stake in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 1.4% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned…
SEB Asset Management AB Invests $356.20 Million in Eli Lilly and Company $LLY
SEB Asset Management AB purchased a new position in Eli Lilly and Company (NYSE:LLY - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased…
Receive a Daily briefing on Pharma Industry News
Get Started